Dr. Steven C. Krause Ph.D. Net Worth

Dr. Steven C. Krause Ph.D. biography

Dr. Steven C. Krause Ph.D. is the Exec. VP of Sales & Marketing at SenesTech Inc.

What is the salary of Dr D?

As the Exec. VP of Sales & Marketing of SenesTech Inc, the total compensation of Dr D at SenesTech Inc is 240,331$. There are 5 executives at SenesTech Inc getting paid more, with Kenneth Siegel having the highest compensation of 996,476$.

How old is Dr D?

Dr D is 61, he's been the Exec. VP of Sales & Marketing of SenesTech Inc since . There are 7 older and 7 younger executives at SenesTech Inc. The oldest executive at SenesTech Inc is Marc Dumont, 76, who is the Independent Director.

What's Dr D's mailing address?

Steven's mailing address filed with the SEC is C/O SENESTECH, INC., 23460 N. 19TH AVE, STE 110, PHOENIX, AZ, 85027.

Insiders trading at SenesTech Inc

Over the last 8 years, insiders at SenesTech Inc have traded over 262,233$ worth of SenesTech Inc stock and bought 999,146 units worth 1,973,633$ . The most active insiders traders include Grover T Wickersham、Kenneth S Siegel、Jacob Steven Leach. On average, SenesTech Inc executives and independent directors trade stock every 24 days with the average trade being worth of 74,077$. The most recent stock trade was executed by Jacob Steven Leach on 16 August 2021, trading 150,000 units of SNES stock currently worth 229,500$.

What does SenesTech Inc do?

senestech is changing the paradigm of pest management by targeting the root cause of the problem: reproduction. contrapest® is an innovative technology that targets the reproductive capabilities of norway and roof rats. as a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down. our delivery system is designed to minimize handler exposure, and contrapest® is dispensed inside tamper resistant bait stations, minimizing the risks to non-target species. as a versatile tool, contrapest® can be used within your integrated pest management program to help reduce reproduction and magnify the success of your ipm protocols or as a standalone, non-lethal solution for customers that are looking to reduce or eliminate their use of lethal methodologies. contrapest® is a restricted use pesticide, due to applicator expertise. please read and comply with all label instructions. fo

SenesTech Inc executives and stock owners

SenesTech Inc executives and other stock owners filed with the SEC include:

• Kenneth Siegel,
  Chief Executive Officer, Director
• Kenneth S. Siegel,
  CEO & Director
• Thomas Chesterman,
  Chief Financial Officer, Executive Vice President, Treasurer, Assistant Secretary
• Thomas C. Chesterman M.B.A.,
  Exec. VP, CFO, Treasurer & Assistant Sec.
• Thomas C. Chesterman,
  Exec. VP, CFO, Treasurer & Assistant Sec.
• Dr. Steven C. Krause Ph.D.,
  Exec. VP of Sales & Marketing
• Kim Wolin,
  Executive Vice President - Operations, Secretary
• Jamie Morrison,
  Independent Chairman of the Board
• Kim Patrice Wolin,
  Exec. VP of Operations & Sec.
• Jake Leach,
  Independent Director
• K. Kavanagh,
  Independent Director
• Phil Grandinetti,
  Independent Director
• Julia Williams,
  Independent Director
• Matthew Szot,
  Independent Director
• Marc Dumont,
  Independent Director
• Delphine Chiavarini,
  Independent Director
• Steve Krause,
  Executive Vice President of Sales and Marketing
• Nicole Williams,
  Chief Strategy Officer
• Robert Blum,
  Investor Relations
• Paul M. Palz,
  VP & Corp. Controller
• Loretta Powers Mayer,
  Chief Scientific Officer
• Grover T Wickersham,
  Director
• Robert E Jr Ramsey,
  Director
• Cheryl Ann Dyer,
  Pres. & Chief Research Officer
• Jacob Steven Leach,
  Director
• Nicole C Williams,
  Chief Strategy Officer
• Joel Lee Fruendt,
  Chief Executive Officer